ClinicalTrials.gov
skipnavHome|Search|Browse|Resources|Help|What's New|About

Browse : By Sponsor : Industry : Eximias Pharmaceutical

Include trials that are no longer recruiting patients.

1 study was found.
1.RecruitingNolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
Conditions: localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...

line
U.S. National Library of Medicine, Contact NLM Customer Service
National Institutes of Health, Department of Health & Human Services
Copyright, Privacy, Accessibility, Freedom of Information Act